LEXEO THERAPEUTICS INC. - COMMON STOCK

3,2400

16-мая-25 16:45:00

15 мин. задержка

Акции

+0,5400

+20,00%

Сегодняшний диапазон

2,6600 - 3,4700

ISIN

N/A

Источник

NASDAQ

Lexeo Therapeutics Announces Oversubscribed $95.0 Million Equity Financing

11 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire
Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

05 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
Lexeo Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

18 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire
Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

11 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.